Medica Radioactive Microspheres are radionuclide-labeled particle sources with a particle size of 20 to 70 μm, such as yttrium-90-glass microspheres, iodine-131-protein microspheres, etc. They are mainly used for arterial embolization and internal irradiation treatment of solid tumors such as liver cancer.

The global Medica Radioactive Microspheres market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime 's newest research report, the “Medica Radioactive Microspheres Industry Forecast” looks at past sales and reviews total world Medica Radioactive Microspheres sales in 2023, providing a comprehensive analysis by region and market sector of projected Medica Radioactive Microspheres sales for 2024 through 2030. With Medica Radioactive Microspheres sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Medica Radioactive Microspheres industry.

This Insight Report provides a comprehensive analysis of the global Medica Radioactive Microspheres landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest development and M&A activity

This report also analyzes the strategies of leading global companies with a focus on Medica Radioactive Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medica Radioactive Microspheres market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medica Radioactive Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medica Radioactive Microspheres.

With the advancement of technology, the preparation method of radioactive microspheres is expected to be further simplified, which will help reduce production costs and thus promote their clinical popularity and application.

This report presents a comprehensive overview, market shares, and growth opportunities of the Medica Radioactive Microspheres market by product type, application, key manufacturers, and key regions and countries.

Segmentation by Type:

• Holmium-166 Microspheres
• Yttrium-90 Microspheres

Segmentation by Application:

• Cancer Treatment
• Organ Imaging
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• Boston Scientific
• Sirtex Medical Limited
• Quirem Medical
• ABK Biomedical
• BTG Medical
• Świerk
• Terumo
• AtomVie Global Radiopharma Inc
• BWXT Medical
• Merit Medical
• Cook Medical

Key Questions Addressed in this Report

1. What is the 10-year outlook for the global Medica Radioactive Microspheres market?
2. What factors are driving Medica Radioactive Microspheres market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Medica Radioactive Microspheres market opportunities vary by end market size?
5. How does Medica Radioactive Microspheres break out by Type, by Application?